These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27011685)

  • 41. [Therapy of acute decompensated heart failure with levosimendan].
    Müller K; Peters A; Zeus T; Hennersdorf M; Strauer BE
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():119-22. PubMed ID: 16802535
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The use of the novel calcium sensitizer levosimendan in critically ill patients.
    Plöchl W; Rajek A
    Anaesth Intensive Care; 2004 Aug; 32(4):471-5. PubMed ID: 15675206
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
    Baysal A; Yanartas M; Dogukan M; Gundogus N; Kocak T; Koksal C
    J Cardiothorac Vasc Anesth; 2014 Jun; 28(3):586-94. PubMed ID: 24447501
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Levosimendan for Perioperative Cardioprotection: Myth or Reality?
    Santillo E; Migale M; Massini C; Incalzi RA
    Curr Cardiol Rev; 2018; 14(3):142-152. PubMed ID: 29564979
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF; Shekerdemian LS; Nørgaard MA; Brizard CP; Mynard JP; Horton SB; Penny DJ
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Levosimendan enhances cardiac performance after cardiopulmonary bypass: a prospective, randomized placebo-controlled trial.
    Nijhawan N; Nicolosi AC; Montgomery MW; Aggarwal A; Pagel PS; Warltier DC
    J Cardiovasc Pharmacol; 1999 Aug; 34(2):219-28. PubMed ID: 10445673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A comparison of dobutamine and levosimendan on hepatic blood flow in patients with a low cardiac output state after cardiac surgery: a randomised controlled study.
    Alvarez J; Baluja A; Selas S; Otero P; Rial M; Veiras S; Caruezo V; Taboada M; Rodriguez I; Castroagudin J; Tome S; Rodriguez A; Rodriguez J
    Anaesth Intensive Care; 2013 Nov; 41(6):719-27. PubMed ID: 24180712
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Levosimendan vs. intra-aortic balloon pump in high-risk cardiac surgery.
    Lomivorotov VV; Cherniavskiy AM; Boboshko VA; Kornilov IA; Lomivorotov VN; Karaskov AM
    Asian Cardiovasc Thorac Ann; 2011 Apr; 19(2):154-9. PubMed ID: 21471262
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A; Alvaro G; Pisano A; Guarracino F; Lobreglio R; Bradic N; Lembo R; Gianni S; Calabrò MG; Likhvantsev V; Grigoryev E; Buscaglia G; Pala G; Auci E; Amantea B; Monaco F; De Vuono G; Corcione A; Galdieri N; Cariello C; Bove T; Fominskiy E; Auriemma S; Baiocchi M; Bianchi A; Frontini M; Paternoster G; Sangalli F; Wang CY; Zucchetti MC; Biondi-Zoccai G; Gemma M; Lipinski MJ; Lomivorotov VV; Landoni G
    Am Heart J; 2016 Jul; 177():66-73. PubMed ID: 27297851
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hemodynamic effects of levosimendan in patients with low-output heart failure after cardiac surgery.
    Labriola C; Siro-Brigiani M; Carrata F; Santangelo E; Amantea B
    Int J Clin Pharmacol Ther; 2004 Apr; 42(4):204-11. PubMed ID: 15124978
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Levosimendan for patients with severely reduced left ventricular systolic function and/or low cardiac output syndrome undergoing cardiac surgery: a systematic review and meta-analysis.
    Sanfilippo F; Knight JB; Scolletta S; Santonocito C; Pastore F; Lorini FL; Tritapepe L; Morelli A; Arcadipane A
    Crit Care; 2017 Oct; 21(1):252. PubMed ID: 29047417
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Levosimendan, a new calcium-sensitizing inotrope for heart failure.
    Ng TM
    Pharmacotherapy; 2004 Oct; 24(10):1366-84. PubMed ID: 15628834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparison of three different regimens of intermittent inotrope infusions for end stage heart failure.
    Bonios MJ; Terrovitis JV; Drakos SG; Katsaros F; Pantsios C; Nanas SN; Kanakakis J; Alexopoulos G; Toumanidis S; Anastasiou-Nana M; Nanas JN
    Int J Cardiol; 2012 Sep; 159(3):225-9. PubMed ID: 21481958
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Use of levosimendan, a new inodilator, for postoperative myocardial stunning in a premature neonate.
    Lechner E; Moosbauer W; Pinter M; Mair R; Tulzer G
    Pediatr Crit Care Med; 2007 Jan; 8(1):61-3. PubMed ID: 17149153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiologic effects of a calcium sensitizer inotrope levosimendan administered intravenously in patients with normal cardiac function.
    Toivonen L; Viitasalo M; Sundberg S; Akkila J; Lehtonen L
    J Cardiovasc Pharmacol; 2000 Apr; 35(4):664-9. PubMed ID: 10774799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of Levosimendan and Milrinone for ECLS Weaning in Patients After Cardiac Surgery-A Retrospective Before-and-After Study.
    Jacky A; Rudiger A; Krüger B; Wilhelm MJ; Paal S; Seifert B; Spahn DR; Bettex D
    J Cardiothorac Vasc Anesth; 2018 Oct; 32(5):2112-2119. PubMed ID: 29748076
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clinical experience with levosimendan in anesthesiology and in the intensive care unit.
    Cavana M; Pignataro C; Fraticelli A; Mebazaa A
    Ital Heart J; 2003 May; 4 Suppl 2():61S-64S. PubMed ID: 14635372
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.
    Erb J; Beutlhauser T; Feldheiser A; Schuster B; Treskatsch S; Grubitzsch H; Spies C
    J Int Med Res; 2014 Jun; 42(3):750-64. PubMed ID: 24781725
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A Randomized Blinded Study of the Left Ventricular Myocardial Performance Index Comparing Epinephrine to Levosimendan following Cardiopulmonary Bypass.
    Salgado Filho MF; Barral M; Barrucand L; Cavalcanti IL; Verçosa N
    PLoS One; 2015; 10(12):e0143315. PubMed ID: 26655803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vasoactive Inotrope Score as a tool for clinical care in children post cardiac surgery.
    Kumar M; Sharma R; Sethi SK; Bazaz S; Sharma P; Bhan A; Kher V
    Indian J Crit Care Med; 2014 Oct; 18(10):653-8. PubMed ID: 25316975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.